Influenza Diagnostics Market Size, Share & Trends Report

Influenza Diagnostics Market Size, Share & Trends Analysis Report By Test Type (RIDT, RT-PCR, Cell Culture), By End-use (Hospitals, Laboratories, POCT), By Region, And Segment Forecasts, 2018 - 2024

  • Published Date: Mar, 2018
  • Base Year for Estimate: 2015
  • Report ID: GVR-1-68038-259-4
  • Format: Electronic (PDF)
  • Historical Data: 2013 - 2015
  • Number of Pages: 76

Table of Contents

Chapter 1 Research Methodology
                1.1 Country wise market: Base estimates
                1.2 Global market: CAGR calculation
                1.3 Region based segment share calculation
                1.4 Research Scope & Assumptions
                1.5 List of Data Sources
                    1.5.1 Data for primary interviews, by sources
                    1.5.2 Data for primary interviews, by region
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Influenza Diagnostics Market Variables, Trends & Scope
                4.1 Market Segmentation & Scope
                4.2 Market driver analysis
                    4.2.1 Rising base of geriatric population (aged 65 years or older)
                    4.2.2 Increasing prevalence of chronic diseases such as respiratory, heart and blood disorders
                    4.2.3 Growing government initiatives to counter influenza
                    4.2.4 Emergence of technologically advanced influenza diagnostics tests
                4.3 Market restraint analysis
                    4.3.1 Product safety and high cost of development
                4.4 Penetration & Growth Prospect Mapping
                4.5 Competitive Landscape: Market Position Analysis
                4.6 Influenza Diagnostics Market - SWOT Analysis, by Factor (Political & Legal, Economic & Technological)
                4.7 Industry Analysis - Porter’s
Chapter 5 Influenza Diagnostics Market: Test Type Estimates & Trend Analysis
                5.1 Influenza Diagnostics Market: Test Type Movement Analysis
                5.2 Rapid Influenza Diagnostic Tests
                    5.2.1 RIDT market, 2013 - 2024 (USD Million)
                5.3 Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
                    5.3.1 RT-PCR market, 2013 - 2024 (USD Million)
                5.4 Cell Culture
                    5.4.1 Cell culture market, 2013 - 2024 (USD Million)
                5.5 Others
                    5.5.1 Others market, 2013 - 2024 (USD Million)
Chapter 6 Influenza Diagnostics Market: End-use Estimates & Trend Analysis
                6.1 Influenza Diagnostics Market: End-use Movement Analysis
                6.2 Hospitals
                    6.2.1 Hospitals market, 2013 - 2024 (USD Million)
                6.3 Point-of-Care Testing
                    6.3.1 POCT market, 2013 - 2024 (USD Million)
                6.4 Laboratories
                    6.4.1 Laboratories market, 2013 - 2024 (USD Million)
Chapter 7 Influenza Diagnostics Market: Regional Estimates & Trend Analysis, by Product
                7.1 Influenza diagnostics Market Share by Region, 2015 & 2024
                7.2 North America
                    7.2.1 U.S.
                    7.2.2 Canada
                7.3 Europe
                    7.3.1 U.K.
                    7.3.2 Germany
                7.4 Asia Pacific
                    7.4.1 China
                    7.4.2 India
                7.5 Latin America
                    7.5.1 Brazil
                    7.5.2 Mexico
                7.6 Middle East and Africa
                    7.6.1 South Africa
                    7.6.2 Saudi Arabia
Chapter 8 Competitive Landscape
                8.1 Company Profiles
                    8.1.1 3M Health Care
                        8.1.1.1 Company overview
                        8.1.1.2 Financial performance
                        8.1.1.3 Product benchmarking
                    8.1.2 Alere
                        8.1.2.1 Company overview
                        8.1.2.2 Financial performance
                        8.1.2.3 Product benchmarking
                        8.1.2.4 Strategic initiatives
                    8.1.3 Becton, Dickinson and Company (BD)
                        8.1.3.1 Company overview
                        8.1.3.2 Financial performance
                        8.1.3.3 Product benchmarking
                    8.1.4 Meridian Bioscience, Inc.
                        8.1.4.1 Company overview
                        8.1.4.2 Financial performance
                        8.1.4.3 Product benchmarking
                    8.1.5 Quidel Corporation
                        8.1.5.1 Company overview
                        8.1.5.2 Financial performance
                        8.1.5.3 Product benchmarking
                    8.1.6 Roche Diagnostics Corporation
                        8.1.6.1 Company overview
                        8.1.6.2 Financial performance
                        8.1.6.3 Product benchmarking
                        8.1.6.4 Strategic initiatives
                    8.1.7 SA Scientific
                        8.1.7.1 Company overview
                        8.1.7.2 Product benchmarking
                    8.1.8 Sekisui Diagnostics
                        8.1.8.1 Company overview
                        8.1.8.2 Product benchmarking
                        8.1.8.3 Strategic initiatives
                    8.1.9 Thermo Fisher Scientific, Inc.
                        8.1.9.1 Company overview
                        8.1.9.2 Financial performance
                        8.1.9.3 Product benchmarking


List of Tables

TABLE 1 Factors used in segment share estimation
TABLE 2 Primary interview details, by source
TABLE 3 Primary interview details, by region
TABLE 4 North America influenza diagnostics market, 2013 - 2024 (USD Million)
TABLE 5 North America influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 6 North America influenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 7 U.S. influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 8 U.S. influenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 9 Canada influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 10 Canada influenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 11 Europe influenza diagnostics market, 2013 - 2024 (USD Million)
TABLE 12 Europe influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 13 Europe influenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 14 U.K. influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 15 U.K. influenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 16 Germany influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 17 Germany influenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 18 Asia Pacific influenza diagnostics market, 2013 - 2024 (USD Million)
TABLE 19 Asia Pacific influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 20 Asia Pacificdiagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 21 China influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 22 China influenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 23 India influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 24 India influenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 25 Latin America influenza diagnostics market, 2013 - 2024 (USD Million)
TABLE 26 Latin America influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 27 Latin America influenzadiagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 28 Brazil influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 29 Brazil influenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 30 Mexico influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 31 Mexico influenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 32 Middle East and Africa influenza diagnostics market, 2013 - 2024 (USD Million)
TABLE 33 Middle East and Africa influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 34 Middle East and Africa influenzadiagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 35 South Africa influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 36 South Africa influenza diagnostics market, by end use, 2013 - 2024 (USD Million)
TABLE 37 Saudi Arabia influenza diagnostics market, by test type, 2013 - 2024 (USD Million)
TABLE 38 Saudi Arabia influenza diagnostics market, by end use, 2013 - 2024 (USD Million)


List of Figures

FIG. 1 Primary interviews, by sources
FIG. 2 Primary interviews, by region
FIG. 3 Influenza diagnostics: Market summary
FIG. 4 Influenza diagnostics: Market trends & outlook
FIG. 5 Market segmentation & scope
FIG. 6 Market driver relevance analysis (Current & future impact)
FIG. 7 Growing geriatric population in the U.S.
FIG. 8 Penetration & growth prospect mapping
FIG. 9 Competitive Landscape Analysis, 2015
FIG. 10 SWOT analysis, by factor (political & legal, economic and technological)
FIG. 11 Porter’s Five Forces Analysis
FIG. 12 Influenza diagnostics market test type outlook : Key takeaways
FIG. 13 Influenza diagnostics market: Test type movement analysis
FIG. 14 Global RIDT market, 2013-2024 (USD Million)
FIG. 15 Global RT-PCR market, 2013-2024 (USD Million)
FIG. 16 Global cell culture market, 2013-2024 (USD Million)
FIG. 17 Global other influenza diagnostics market, 2013-2024 (USD Million)
FIG. 18 Influenza diagnostics market end-use outlook : Key takeaways
FIG. 19 Influenza diagnostics market: End-use movement analysis
FIG. 20 Hospitals market, 2013-2024 (USD Million)
FIG. 21 Global POCT market, 2013-2024 (USD Million)
FIG. 22 Global laboratories market, 2013-2024 (USD Million)
FIG. 23 Regional market place: Key takeaways
FIG. 24 Regional outlook, 2016 & 2024

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.